Skip to main content
Erschienen in: Reactions Weekly 1/2017

01.09.2017 | Case report

Cetuximab

Infusion related reaction: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Excerpt

» Editorial comment: Details of this case report have previously been published [see 1]. The author has stated that the patient received IV cetuximab at 400 mg/m2 as the maintanance dose and 250mg/m2 as loading dose, administered weekly. …
Literatur
1.
Zurück zum Zitat Ikegawa K, et al. Retrospective analysis of anti-allergy prophylaxis for infusion reactions of cetuximab in 248 head and neck cancer patients. Journal of Oncology Pharmacy Practice 22 (Suppl. 1): 3, No. 3, Jun 2016. Ikegawa K, et al. Retrospective analysis of anti-allergy prophylaxis for infusion reactions of cetuximab in 248 head and neck cancer patients. Journal of Oncology Pharmacy Practice 22 (Suppl. 1): 3, No. 3, Jun 2016.
Metadaten
Titel
Cetuximab
Infusion related reaction: case report
Publikationsdatum
01.09.2017
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2017
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-017-35576-6

Weitere Artikel der Ausgabe 1/2017

Reactions Weekly 1/2017 Zur Ausgabe

Case report

Vedolizumab

Case report

Methazolamide

Case report

Simeprevir

Case report

Heparin